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Genetic evidence for a novel gene(s) involved in urogenital Monosomy for the distal 10q region is frequently asso-
development on 10q26. ciated with urogenital anomalies such as vesicoureteral
Background. Although the frequent association between reflux (VUR), renal hypoplasia, micropenis, hypospa-distal 10q monosomy and urogenital anomalies suggests the
dias, cryptorchidism, and hypoplastic labia majora [1].presence of a gene(s) for urogenital development on distal 10q,
In particular, monosomy for the 10q26 region has beenmolecular deletion mapping has not been performed for the
putative gene(s). In this study, we examined genotype-pheno- identified in individuals with urogenital anomalies in two
type correlations in patients with distal 10q monosomy. large families [2, 3], in a mother and son with urinary
Methods. This study consisted of six karyotypic males (cases
anomalies [4], and in a patient with complete male to1 through 6) and four karyotypic females (cases 7 through 10)
female sex reversal [5]. These findings suggest that awith 10q26 monosomy. Cases 3 through 5 and 7 through 10 had
urinary anomalies such as vesicoureteral reflux and hypoplastic gene(s) for urogenital development resides in 10q26 and
kidney, and cases 1 through 6, 8, and 9 exhibited genital anoma- that haploinsufficiency of the gene(s) results in the devel-
lies such as micropenis, hypospadias, cryptorchidism, and hypo- opment of urogenital anomalies. However, molecularplastic labia majora. Fluorescence in situ hybridization (FISH)
studies have not been carried out in patients with distalfor 10q telomere, whole chromosome 10 painting, and micro-
satellite analysis for 35 loci on distal 10q were performed in 10q monosomy so that genotype-phenotype correlations
cases 1 through 8. remain to be determined for the putative gene(s).
Results. FISH and whole chromosome painting confirmed In this article, we report on clinical and genetic findingsdistal 10q monosomy in cases 1 through 8. Microsatellite analy-
in 10 nonmosaic Japanese patients with distal 10q mono-sis revealed that hemizygosity for the region distal to D10S186
somy, and we discuss the putative gene(s) for urogenitalwas shared by cases with urinary anomalies and that for the
region distal to D10S1248 was common to cases with genital development.
anomalies. Furthermore, it was indicated that PAX2, GFRA1,
and EMX2 on distal 10q, in which the deletions could affect
urinary and/or genital development, were present in two copies METHODS
in cases 1 through 8.
PatientsConclusions. The results suggest that a novel gene(s) for
urinary development and that for genital development reside This study consisted of six karyotypic males (cases 1
in the approximately 20 cM region distal to D10S186 and in the
through 6) and four karyotypic females (cases 7 throughapproximately 10 cM region distal to D10S1248, respectively,
10) with 10q26 monosomy. Age and karyotype of eachalthough it remains to be determined whether the two types
of genes are identical or different. case are shown in Table 1, together with parental karyo-
types in cases 1 through 4 and 6 through 10. Cases 1 and
2 have been reported previously [8, 9]. All cases shared
monosomy for 10q26 in common. Cases 1 through 4,
7, and 9 had apparently simple 10q deletions, and theKey words: 10q26 monosomy, genotype-phenotype correlation, uri-
nary anomalies, genital anomalies, hemizygosity, deletion mapping. remaining cases had unbalanced der(10) chromosomes.
Case 3 had an elongated 9p chromosome (9ph), which
Received for publication April 12, 2000
was also found in the normal father, and case 4 hadand in revised form June 6, 2000
Accepted for publication June 9, 2000 an inv(9) chromosome, which was also detected in the
normal mother.Ó 2000 by the International Society of Nephrology
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Fig. 1. Clinical findings of case 4. (A) Void-
ing cystourethrography (VCG), showing left
vesicoureteral reflux (VUR; grade 3) and
hydronephrosis. (B) External genitalia, with
micropenis, bifid scrotum, hypospadias, and
undescended testes.
Clinical features are summarized in Table 1. Cases 3 tive days; blood sampling on the first and fourth days).
In case 2, primary hypogonadism was suggested at onethrough 5 and 7 through 10 had urinary anomalies such
as VUR and hypoplastic kidney (Fig. 1A); cases with year of age, with an insufficient testosterone response
(,5 ! 60 ng/dL) in an hCG test. In case 4, endocrineVUR had recurrent urinary tract infection, and case 5
received peritoneal dialysis from 12 years of age. It re- results were not remarkable at seven months of age, with
a sufficient testosterone response (,5 ! 410 ng/dL) inmained uncertain, however, whether VUR was indeed
absent in cases 5 and 6 who did not receive voiding cysto- an hCG test, but suggested primary hypogonadism at 3.5
years of age, with an insufficient testosterone responseurethrography (VCG). Cases 1 through 6, 8, and 9 exhib-
ited genital anomalies such as micropenis, hypospadias, (,5 ! 100 ng/dL) in an hCG test and an exaggerated fol-
licle-stimulating hormone response (1.3 ! 17.8 mIU/mL)cryptorchidism, and hypoplastic labia majora (Fig. 1B);
case 1 underwent orchidopexy at eight years of age, and in a gonadotropin releasing hormone test (100 mg/m2
bolus intravenous; blood sampling at 0, 30, 60, 90, andcase 4 received a surgical repair of hypospadias and or-
120 minutes).chidopexy at 3.7 years of age. Cases 2 through 5, 9, and
Gonadal histology was examined in cases 1, 2, and 410 had cardiovascular anomalies such as patent ductus
by an open biopsy at the time of operation (cases 1arteriosus (PDA); case 2 underwent ligation of PDA at
and 4) or by a needle biopsy at one year of age (case 2).10 months of age, and case 3 received surgical operation
Seminiferous tubules were well developed with Sertoliand drug therapy for tetralogy of Fallot. In addition,
cells and spermatogonia in case 1, dysgenetic and com-case 1 had anal atresia, which was surgically treated
posed exclusively of Sertoli cells in case 2, and well pre-shortly after birth, and case 10 had laryngomalacia, which
served with Sertoli cells and spermatogonia but occasion-required tracheostomy at five months of age. All cases
ally associated with calcification indicative of testicularmanifested various degrees of growth failure, mental
dysfunction in case 4. Leydig cells were barely presentretardation, and minor anomalies. However, computed
in the interstitial space in the three cases.tomography showed no brain anomalies, except for non-
specific atrophic changes, in cases 3, 4, and 7 through 10,
Molecular cytogenetic studiesand ophthalmologic examination was normal in cases 3, 4,
7, and 9. Case 9 died of cardiac failure at 12 years of age, Fluorescence in situ hybridization (FISH) analysis was
performed for metaphase spreads prepared from periph-and case 10 died of respiratory failure at 14 months of age.
Endocrine studies were performed in cases 1, 2, and 4. eral lymphocytes or lymphoblastoid cell lines of cases 1
through 8 and their parents; using a 10q telomere probe,In case 1, endocrine data were grossly normal at eight
years of age, with a good testosterone response (20 ! a 10p telomere probe used as an internal signal control,
and a whole chromosome 10 painting probe. In addition,270 ng/dL) in a human chorionic gonadotropin (hCG)
test (3000 IU/m2/dose intramuscularly for three consecu- FISH for DMRT-1/DMRT-2 [a candidate(s) for the 9p
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sex-determining gene] [10] and whole chromosome 9 Microsatellite analysis
painting were performed in case 3 and his father; 6p Representative results are shown in Figure 3, and the
telomere FISH and whole chromosome 6 painting were data are summarized in Table 2. Genotyping analysis
carried out in case 6 and his father, and 8q telomere with the use of parental DNA confirmed distal 10q mo-
FISH and whole chromosome 8 painting were carried nosomy with the breakpoints between D10S1141 and
out in case 8 and her father. The telomere probes were D10S1230 in case 1, between D10S1141 and D10S1483
as described in the study of Ning et al [11], and the probe in case 2, between D10S209 and D10S1679 in case 3,
for DMRT-1/DMRT-2 was prepared by MBC Labora- between D10S1679 and D10S587 in case 4, between
tory (Tokyo, Japan). These probes were labeled with D10S1248 and D10S1770 in case 6, between D10S1679
digoxigenin and detected by rhodamine antidigoxigenin and D10S587 in case 7, and between D10S186 and
or labeled with biotin and were detected by avidin conju- D10S1782 in case 8. The deleted chromosome 10 was of
gated to fluorescein. The whole chromosome painting maternal origin in case 1 and of paternal origin in cases
probes were purchased from Vysis (Downers Grove, IL, 2 through 4 and 6 through 8. In case 5, single peaks only
USA); the signal detection was carried out according to were detected for all of the 19 loci distal to D10S1679,
the manufacturer’s protocol. providing further support for the distal 10q monosomy.
In addition, the 9p sex-determining region distal to
Microsatellite analysis D9S1779 was indicated to be present in two doses in
cases 1 through 8.Genomic DNA was extracted from peripheral leuko-
cytes or lymphoblastoid cell lines of cases 1 through 8
and the parents of cases 1 through 4 and 6 through 8 DISCUSSION
and was amplified by polymerase chain reaction (PCR)
Clinical assessment of cases 1 through 10 showed uri-with primers defining 35 loci on the distal 10q region
nary anomalies in 7 cases, genital anomalies in 8 cases,(Table 2). In addition, four loci on the distal 9p region
and cardiovascular anomalies in 6 cases, together withwere analyzed [the 9p sex-determining gene(s) has been
anal and laryngeal anomalies in single cases. The clinicalmapped to a roughly 250 kb region distal to D9S1779;
features are reminiscent of those of 94 patients pre-Table 2] [13]. Amplification was performed in a reaction
viously reported with distal 10q monosomy (Table 3).volume of 50 mL containing 0.3 mg genomic DNA, 20
Although urinary anomalies are more frequent in thispmol fluorescently labeled forward primer, 20 pmol unla-
study than in the previous studies, this may be due tobeled reverse primer, 0.2 mmol/L dNTPs, and 2 U Taq
underestimation of urinary anomalies in the previous
polymerase. The primer sequences and the PCR condi-
reports. In contrast to genital and cardiovascular anoma-
tions were as described in the Genome Database (http:// lies, which are identified by routine physical examination
www.gdb.org/). The PCR products were determined for and auscultation, urinary anomalies may be overlooked
the fragment size on ABI PRISM 310 autosequencer without specific investigations such as ultrasound or ra-
using GeneScan software (Applied Biosystems, Foster diological studies. In this context, the prevalence of VUR
City, CA, USA). may be underestimated in the present study, because
VCG was not performed in cases 5 and 6.
Anomalous features in aneuploidies are primarily as-RESULTS
cribed to two factors. One factor is a dosage effect of aMolecular cytogenetic studies
specific gene(s) on the chromosomal region involved. It
The 10q telomere probe detected positive signals on has been suggested that an altered copy number of a
the normal chromosome 10 alone in cases 1 through 8, dosage-sensitive gene(s) for human development leads
demonstrating partial monosomy of distal 10q in these to malformations characteristic of each aneuploidy [14].
cases (Fig. 2A). The chromosome 10 painting probe ho- The other factor is chromosome imbalance common to
mogeneously stained both the normal and the abnormal various aneuploidies. It has been suggested that chromo-
chromosome 10 of cases 1 through 4 and 7, confirming some imbalance disturbs developmental homeostasis, re-
simple deletions in these cases (Fig. 2B). In case 5, the sulting in nonspecific anomalies shared by various aneu-
distal portion of the abnormal chromosome 10 remained ploidies [14, 15]. Thus, major anomalies in distal 10q
unstained with the chromosome 10 painting probe, indi- monosomy would be assessed as follows (Tables 1 and 3):
cating an unbalanced der(10) chromosome. Case 3 and (1) urinary anomalies would primarily be due to a gene
his father were shown to have a 9ph chromosome with dosage effect, because they rarely occur in other aneu-
two copies of DMRT-1/DMRT-2. Cases 6 and 8 were ploidies [16]; (2) genital anomalies may be due to both
demonstrated to have unbalanced der(10) chromosomes, chromosome imbalance and a gene dosage effect, be-
and their fathers were shown to have reciprocal translo- cause most of them are nonspecific features observed in
various aneuploidies, and on the other hand, the highcations involving distal 10q.
Ogata et al: Urogenital development gene(s) on 10q26 2285
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Fig. 2. Molecular cytogenetic findings in case
4. (A) Telomere fluorescence in situ hybridi-
zation (FISH) analysis. Only a single signal is
detected for the 10q telomere (arrow), whereas
two signals are found for the 10p telomere (ar-
rowheads). (B) Whole chromosome 10 paint-
ing. Both the normal chromosome 10 (arrow)
and the deleted chromosome 10 (arrowhead)
are homogeneously stained.
Fig. 3. Microsatellite analysis in case 4. Leu-
kocyte genomic DNA was amplified by poly-
merase chain reaction (PCR) with fluores-
cently labeled forward primer and unlabeled
reverse primer, and the PCR products were
mixed with internal control size markers and
were electrophoresed on an autosequencer
(ABI PRISM 310). The size of the PCR prod-
ucts was determined by GeneScan software
version 2.1. D10S1723: Paternal markers are
not inherited by the patient, and one of the
two maternal markers alone is transmitted to
the patient, demonstrating hemizygosity of
this locus in the patient. The peak size is as
follows: 161 bp and 163 bp for the father, 145
bp for the patient, and 145 bp and 161 bp for
the mother. D10S1679: The patient is hetero-
zygous with the maternally derived and the
paternally derived peaks. The peak size is as
follows: 203 bp and 205 bp for the father, and
203 bp and 213 bp for the patient and the
mother.
prevalence of genital anomalies and the occurrence of [17]. Thus, a gene dosage effect would primarily be pos-
tulated for urinary and genital anomalies.sex reversal are barely observed in other aneuploidies
[5, 16]; and (3) cardiovascular anomalies would primarily The region distal to D10S186 was deleted in all the
molecularly analyzed patients with urinary anomaliesbe due to chromosome imbalance, because most of them
are nonspecific anomalies common to most aneuploidies (cases 3 through 5, 7, and 8). This implies that a gene(s)
for urinary development may lie in this region that is(by contrast, aortic coarctation in Turner syndrome and
endocardial cushion defect in Down syndrome are attrib- estimated to span approximately 20 cM according to the
linkage map of Marshfield Medical Research Foundationutable to the dosage effect of specific genes, because they
occur most frequently in Turner and Down syndrome, (http://www.marshmed.org/genetics/). Although urinary
anomalies are diverse, this is not necessarily inconsistentrespectively, and rarely take place in other aneuploidies)
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Table 3. Review of patients with partial monosomy of the 10q25–26 regiona
Karyotypic male Karyotypic female
(N 5 55) (N 5 39)
Type of 10q deletions
Simple terminal/interstitial 10q deletion 18 19
Ring chromosome 10 6 5
Derivative chromosome 10 31 15
Paternal 9/31 4/15
Maternal 21/31 10/15
De novo 1/31 1/15
Clinical features
Genital region 44/55 (80%)b 5/39 (12.8%)b
Complete sex reversal 1 —
Ambiguous genitalia 5 2
Cryptorchidism 35 —
Micropenis 21 —
Hypoplastic scrotum 12 —
Hypospadias 9 —
Hypoplastic labia majora or minora — 3
Urinary region 14/55 (25.5%)b 12/39 (30.8%)b
Vesicoureteral reflux 3 4
Hydronephrosis or hydroureters 6 6
Dysplastic, hypoplastic, or cystic kidney 2 5
Posterior urethral valve 3 0
Horseshoe or lump kidney 2 0
Malrotated or ectopic kidney 2 0
Thick-walled bladder 1 1
Anorectal region 5/55 (9.0%)b 4/39 (10.3%)b
Cloaca 0 2
Anal atresia 3 3
Anteriorly displaced anus 2 0
Cardiovascular region 22/55 (40.0%)b 14/39 (35.9%)b
Ventricular septal defect 9 5
Patent ductus arteriosus 6 6
Atrial septal defect 4 1
Tetralogy of Fallot 3 2
Double outlet right ventricle 1 1
Aortic stenosis 0 1
Coarctation of the aorta 1 0
Truncus arteriosus 0 1
Others
Cleft lip or palate 6 5
Inguinal hernia 7 1
Umbilical hernia 2 4
Gastroesophageal reflux 3 2
Sacral dimple 3 0
Single umbilical artery 0 2
The patient number is given in each row.
a The reference list for Table 3 is available from the authors on request
b Indicating the ratio (percentage) of patients with at least one of the features in each category
with a single gene defect. For example, mutations of the not imply that the putative gene(s) resides proximal to
D10S1770. For urinary anomalies, Feather et al haveangiotensin type 2 receptor gene are known to result in
variable patterns of urinary anomalies, including VUR, performed a genome-wide search for VUR susceptibility
loci in seven families with dominantly inherited nonsyn-megaureter, and dysplatic kidney, because of delayed
apoptosis of undifferentiated mesenchymal cells sur- dromic VUR [20]; although they identified several sus-
ceptibility regions especially on 1p13, no significant link-rounding the Wolffian duct and ureter during the renal
and urinary tract development [18]. Similarly, although age was found to 10q. However, this would not argue
against our results, because VUR is a genetically hetero-cases 1 and 2 had no urinary anomalies under hemizygos-
ity for the region distal to D10S186, this does not neces- geneous disorder [20, 21]. In addition, since a relatively
small number of families were studied with markers atsarily argue against the presence of a gene for the urinary
development. Haploinsufficiency of genes involved in roughly 10 cM intervals [20], a possible linkage to distal
10q may be undetected.human development is usually associated with a wide
range of penetrance and expressivity [19]. By analogy, The region distal to D10S1248 was deleted in all the
molecularly analyzed patients with genital anomaliesthe apparent lack of urinary anomalies in case 6 would
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(cases 1 through 6 and 8). This suggests that a gene(s)
for genital development may reside in this region, which
is estimated to span approximately 10 cM according to
the linkage map of Marshfield Medical Research Foun-
dation. In this context, since both karyotypic males and
females have genital anomalies, and endocrine and histo-
logic studies in cases 2 and 4 imply primary hypogonad-
ism. The putative gene(s) for genital development may
be involved in the development of external and internal
genitalia of both sexes [in addition, the gene(s) might
also be related to anorectal anomalies in a small portion
of patients; Tables 1 and 3]. Although there are a var-
iety of genital anomalies, this is common to genetic disor-
ders of sex development [22]. Similarly, although case 7
had apparently normal genitalia under hemizygosity for
the region distal to D10S1248, this would be explained
by assuming that the effect of haploinsufficiency of the
putative gene(s) remained at a subclinical level in case 7.
For genital anomalies, the complete male to female sex
reversal in the patient reported by Wilkie et al is remark-
able [5]. There are three possible explanations for this
exceptional case: (1) this patient may exhibit an extreme
affected end of the phenotypic spectrum caused by hap-
loinsufficiency of the putative gene(s); (2) the putative
gene(s) may be mutated on the apparently normal chro-
mosome 10, resulting in nullisomy for the gene(s); and
(3) sex reversal may be independent of the 10q monosomy.
For the putative gene(s) for urogenital development,
two matters should be pointed out. First, although it
remains to be determined whether the gene(s) for urinary
development and that for genital development are iden-
tical or different, currently available data favor the possi- Fig. 4. Chromosomal location of five genes (RET, PAX2, GFRA1,
bility that the two genes are independent. The association EMX2, and FGFR2) known to be involved in urinary and/or gen-
ital development and that of D10S186 and D10S1248 defining the proxi-of urinary anomalies with distal 10q monosomy has been
mal boundaries of the critical regions for urinary and genital develop-found in a fertile mother and her son [4], and urinary ment, respectively, proposed in this study. The position of each locus
anomalies have been undetected in the sex-reversed pa- is based on the Genome Database (http://www.gdb.org) and the report
on the International Workshop on Human Chromosome 10 Mappingtient [5]. Second, although the deleted 10q chromosomes
[23]. The ideogram on the left side denotes the G-banding pattern ofwere of paternal origin in 7 of 8 informative patients the 10q chromosome.
(cases 1 through 4, 6 through 8, and 10), the possibility
of epigenetic imprinting is unlikely for the 10q gene(s).
In two large pedigrees with translocations involving 10q,
ever, RET is located on 10q11.2, and microsatellite anal-the urogenital anomalies are similar between patients
ysis indicates that PAX2 and GFRA1, as well as EMX2with paternally and maternally derived distal 10q mono-
assigned proximal to D10S190 (around D10S221) [23],somy [2, 3]. In addition, the origin of der(10) chromo-
are present in two copies in cases 1 through 8 (Table 2).somes can be both paternal and maternal (Table 3).
Furthermore, although heterozygous PAX2 mutationsTo date, five genes on 10q have been postulated to
result in renal coloboma syndrome rather than isolatedhave a positive role in the urinary and/or genital develop-
urinary anomalies [28, 29], coloboma was undetected inment (Fig. 4). For RET, PAX2, GFRA1, and EMX2,
cases examined for ocular lesions. Similarly, althoughknockout mouse experiments have demonstrated that
heterozygous EMX2 mutations cause schizencephalyRet deficiency causes severely compromised formation
rather than urogenital anomalies [30], schizencephalyof kidneys and ureters [24], Pax2 deficiency results in
was absent in cases examined for brain anomalies. Inagenesis of kidneys, ureters, and genital ducts [25], Gfra1
addition, no mutations have been found for GFRA1deficiency causes severely impaired formation of kidneys
[12]. For FGFR2, activating mutations can cause Apertand ureters [26], and Emx2 deficiency leads to agenesis
of kidneys, ureters, gonads, and genital ducts [27]. How- syndrome, which is occasionally associated with renal
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and partial XY sex reversal associated with terminal deletion ofanomalies [31, 32]. However, FGFR2 is located between
10q: Report of 2 cases and literature review. Am J Med Genet
D10S209 and D10S587 [23], proximal to the critical re- 46:597–600, 1993
6. Fujieda K, Matsuura N: Growth and maturation in the malegions for urinary and genital development defined in this
genitalia from birth to adolescence. I. Change of testicular volume.study (Table 2), and urogenital abnormalities in distal
Acta Paediatr Jpn 29:214–219, 1987
10q monosomy are ascribed to haploinsufficiency of a 7. Fujieda K, Matsuura N: Growth and maturation in the male
genitalia from birth to adolescence. II. Change of penile length.responsible gene(s) rather than activating mutations of
Acta Paediatr Jpn 29:220–223, 1987that gene(s). Furthermore, the Apert syndrome pheno-
8. Mutoh A, Sasagawa I, Tateno T, Sawamura T, Nakada T: Long
type is absent in patients with distal 10q monosomy (Ta- arm deletion of chromosome 10 in a boy with monorchidism. Scand
J Urol Nephrol 33:77–78, 1998bles 1 and 3). Thus, the gene(s) for urogenital develop-
9. Suzuki Y, Sasagawa I, Nakada T, Onmura Y: Bilateral cryptor-ment proposed here appears to be a novel one.
chidism associated with terminal deletion of 10q. Urol Int 61:186–
It should be pointed out that although cardiac anoma- 187, 1998
10. Raymond CS, Parker ED, Kettlewell JR, Brown LG, Page DC,lies appear to be attributable to chromosome imbalance,
Kusz K, Jaruzelska J, Reinberg Y, Flejter WL, Bardwell VJ,this would not necessarily exclude the possibility that a
Hirsch B, Zarkower D: A region of human chromosome 9p re-
gene(s) for cardiac development is present on 10q. In quired for testis development contains two genes related to known
sexual regulators. Hum Mol Genet 8:989–996, 1999this regard, the region distal to D10S1679 was deleted in
11. Ning Y, Roschke A, Smith ACM, Macha M, Precht K, Riethmanall of the molecularly analyzed patients with cardiac anom-
H, Ledbetter DH, Flint J, Horsley S, Regan R, Kearney L,
alies (cases 2 through 5). Thus, if a gene(s) for cardiac Knight S, Kvaloy K, Brown WRA: A complete set of human
telomeric probes and their clinical application. Nat Genet 14:86–89,development exists on distal 10q, it would be assigned
1996to a region distal to D10S1679.
12. Shefelbine SE, Khorana S, Schultz PN, Huang E, Thobe N,
In summary, the present study suggests that a novel Hu JH, Fox GM, Jing S, Cote GJ, Gagel RF: Mutational analysis
of the GDNF/RET-GDNFa signaling complex in a kindred withgene(s) for urogenital development resides on distal 10q,
vesicoureteral reflux. Hum Genet 102:474–478, 1998with the critical region being defined by D10S189 for
13. Flejter WL, Fergestad J, Gorski J, Varvilli T, Chandrasekhar-
urinary anomalies and by D10S1248 for genital anoma- appa S: A gene involved in XY sex reversal is located on chromo-
some 9, distal to marker D9S1779. Am J Hum Genet 63:794–802,lies. Further studies in similarly affected patients and
1998identification of a submicroscopic deletion in patients
14. Epstein CJ: The Consequences of Chromosome Imbalance: Princi-
with urological and/or genital abnormalities will permit ples, Mechanisms, and Models. Cambridge, Cambridge University
Press, 1986a better localization of the putative gene(s) for urogenital
15. Gilbert EF, Opitz JM: Developmental and other pathologicdevelopment.
changes in syndromes caused by chromosome abnormalities. Per-
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